Rejuvenation Technologies, founded by John Ramunas and Glenn Markov, is working on RTI-IMM for an undisclosed condition related to the immune system. With a deep focus on telomere attrition, the company aims to provide innovative solutions to age-related challenges.
×
Rejuvenation Technologies � RTI-IMM (NA1)
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD